SAR339658

DRUG2 trials

Sponsors

Sanofi

Conditions

Ulcerative Colitis

Phase 2

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

TerminatedNCT01659138

SanofiUlcerative Colitis

Start: 2012-08-31End: 2016-04-30Updated: 2016-07-13

Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)

TerminatedNCT01861249

SanofiUlcerative Colitis

Start: 2013-07-31End: 2016-04-30Updated: 2016-07-13